Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dallah Healthcare Co's Other Operating Expense for the
three
months ended in Jun. 2026 was ﷼-16 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ﷼641 Mil.
Dallah Healthcare Co's quarterly Other Operating Expense
declined
from Dec. 2025 (﷼653 Mil) to Mar. 2026 (﷼12 Mil) and
declined
from Mar. 2026 (﷼12 Mil) to Jun. 2026 (﷼-16 Mil).
Dallah Healthcare Co's annual Other Operating Expense
increased
from Dec. 2023 (﷼399 Mil) to Dec. 2024 (﷼464 Mil) and
increased
from Dec. 2024 (﷼464 Mil) to Dec. 2025 (﷼579 Mil).
Dallah Healthcare Co Other Operating Expense Related Terms
Dallah Healthcare Co Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼641 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ﷼641 Mil mean?
Dallah Healthcare Co (SAU:4004) has a Other Operating Expense of ﷼641 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Dallah Healthcare Co and its competitors.
Is Dallah Healthcare Co's Other Operating Expense too high?
Dallah Healthcare Co's current Other Operating Expense is ﷼641 Mil. Overall, Dallah Healthcare Co has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Other Operating Expense compare to HCA and THC?
Dallah Healthcare Co's Other Operating Expense of ﷼641 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Dallah Healthcare Co and its competitors. Dallah Healthcare Co's current Other Operating Expense is ﷼641 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼197.11, compared to a current price of ﷼85.00 — trading 56.9% below its estimated fair value. The current Other Operating Expense is ﷼641 Mil. Dallah Healthcare Co's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Other Operating Expense is ﷼641 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼85.00 is trading 56.9% below its estimated GF Value™ of ﷼197.11.
GuruFocus considers Dallah Healthcare Co to be Significantly Undervalued.
Key valuation signals for SAU:4004:
Other Operating Expense: ﷼641 Mil
GF Value™: ﷼197.11 vs. price of ﷼85.00 (56.9% below fair value)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
85GF Score
Get the complete analysis for SAU:4004
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
